Houston Methodist Research Institute scientists recently made a surprise discovery that could potentially change the way cholesterol is treated.
The accidental breakthrough began as an innocuous task.
Bingqing Xu, a third-year medical student from China, joined a research program led by Henry Pownall, Ph.D., professor of bioenergetics at the Houston Methodist Research Institute. One of the program’s goals was to assist Xu in publishing a paper. Since no one had fully validated the current model of cholesterol transport from the arteries to the liver, Pownall decided that it would be an appropriate topic for Xu to explore. Little did they know that her research would lead them to new evidence that challenges a decades-long assumption of how the body processes and eliminates cholesterol.
“It was a very benign proposal. It was going to be easy, nothing controversial,” Pownall said, “but it turned out that the hypothesis was not valid. She found something totally opposite.”
For four decades, the medical community has believed that cholesterol travels from the arteries, becomes absorbed by a particle and remains in the blood for three to five days before being excreted from the body by the liver. However, Pownall and his team showed that a nascent form of cholesterol known as free cholesterol—an early form of high-density lipoprotein (HDL) cholesterol, often referred to as “good” cholesterol—bypasses this process and instead travels directly from the particle to the liver within two to three minutes, a thousand times faster than scientists had previously believed.
“We’re not erasing 40 years of history, but we’re definitely updating and bringing to light mechanisms that other people had not previously researched because they just took for granted that there was only one pathway,” said Corina Rosales, Ph.D., an assistant research professor of bioenergetics at Houston Methodist Research Institute. “We’re trying to find those correct pathways and not just follow everybody else. It’d then be like the blind leading the blind, in a sense.”
Many clinical trials use drugs to inhibit the transfer of cholesteryl ester, a mature form of cholesterol found in the body. The drugs are designed to reduce the risk of atherosclerosis, a precursor for heart attack and stroke caused by the buildup of cholesterol in the arteries. However, a number of the drugs failed to yield any meaningful clinical improvement or led to death, despite increasing “good” cholesterol levels.
“There were at least three different forms of inhibitors that have been duds because they were focused on the wrong aspect of HDL biology,” said Baiba Gillard, Ph.D., an assistant research professor of bioenergetics at the Houston Methodist Research Institute. “We’re hoping our refocus will be more productive.”
Equipped with the new understanding that free cholesterol is eliminated from the body by the liver much faster than cholesteryl ester, the team said they believe their findings will encourage scientists to take a closer look at how HDL cholesterol contributes to cardiovascular disease and how to increase HDL cholesterol levels in ways that are beneficial to the heart, thus opening the door to more effective therapies.
“The most important thing is that we really need to elucidate all the proper mechanisms and pathways for cholesterol and other lipids in order to develop good therapeutics,” Rosales said. “If you don’t know the pathways or if you don’t know how they’re metabolized, then you can’t really develop a good therapeutic agent to treat … lipid disorders, atherosclerosis or conditions like that.”
The team plans to continue their research in partnership with the Houston Methodist cardiology department to test patients’ plasma and determine how “good” cholesterol has affected their heart health.
Baby shower help for 50 Veteran mothers at Miami VA hospital https://t.co/gzMBOgxeit via @wsvn
RT @bilalmomhammad: Great to see our pathology colleagues at @utmbhealth doing so well !!! @utmbnews @UTMB_Pathology @UTMBProvost https://t…
MD Anderson Cancer Center@MDAndersonNews
Daughter, caregiver Carrick Terhune shares the creative ways she supported her mom through #protontherapy for a rare #headandneckcancer: https://t.co/MpKEHxoaQO @MDAProtons #hncsm #endcancer
Researchers from Baylor College of Medicine, @MethodistHosp and @TexasChildrens receive a Specialized Center of Research grant to expand blood cancer therapy options. https://t.co/IcGckHPSBM #grants #cancer #research
RT @BruceTjadenMD: Here at @UTCVSurgery and @UTHealth, we are carrying out a #randomized #ClinicalTrial to compare #medical management vs #…
Veteran Affairs Office in Des Moines, IA holding coat drive https://t.co/IUDLZBpiZF via @weareiowa5news
RT @MillionHeartsUS: #Stroke risk increases with age, but strokes can (and do) happen at any age. Raise awareness of the importance of stro…
RT @BCMHouston_News: We are pleased to welcome Dr. Alastair Thompson to @bcmhouston! Dr. Thompson will lead #breastcancer surgical oncology…
MD Anderson Cancer Center@MDAndersonNews
“We’re really hopeful that we can identify a group of women who can get a much bigger and longer response,” says our @JenniferLitton of #immunotherapy to treat #breastcancer. #endcancer https://t.co/vv1JYis5rl
RT @HRSonline: Sudden #cardiacarrest claims 1 life every 90 secs. A few #SCA risk factors include a previous #heartattack, family history o…
The Dallas, TX VA and Vet Center teams met last week with leadership from the Urban Inter-Tribal Center of Texas to outline how their respective organizations can join forces to effectively reach and serve American Indian and Alaska Native Veterans. https://t.co/EBX1x6cPoV
RT @RiceUGPS: Lots of positive change coming to campus: the university is studying ways to create safe pathways for cyclists, and has also…
TAMU Health Sciences@TAMHSC
The Good Run . . . #MilesforSmiles in its 10th yearOn Nov. 3, the @TAMUdental student-led Miles for Smiles continues its stride at Exall Park in Dallas with its 10th annual runathon. https://t.co/5PFPnaDnOL#TAMHSC #AggieHealth #TAMUHealth #Dentistry #DentalStudents #TAMU https://t.co/NJaxKMawVq
University of Houston@UHouston
The John O'Quinn Foundation donates $3.5M to the UH College of Medicine, UH researchers envision in-home rehab for stroke patients, and Valenti students produce a web cooking show — here are your 60-second highlights of what's happening at UH #UHMoment https://t.co/1ork3iw0kz
CHI St. Luke's Health@CHI_StLukes
Sometimes it’s difficult to sift through the rumors to get the facts about #BreastCancer. We’re debunking five common myths, and they just might surprise you: https://t.co/pMnncNr4ul https://t.co/0HNfCjQYgI